tradingkey.logo
tradingkey.logo

Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results

ReutersMar 12, 2026 10:20 AM

- Gyre Therapeutics Inc GYRE.O:

  • GYRE THERAPEUTICS Q4 PRETAX PROFIT USD -66 THOUSAND

  • GYRE THERAPEUTICS Q4 REVENUE USD 37.195 MILLION

  • GYRE THERAPEUTICS Q4 OPERATING PROFIT USD 118 THOUSAND

Further company coverage: [GYRE.O ]

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

KeyAI